Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Discover which cash back cards have no fees. Find your ideal card and enjoy rewards without extra costs.
28,185 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
As Berkshire's new leader, Greg Abel faces a massive cash pile. This article examines why Alphabet is the target, wha...
Retirees face a tough choice as Netflix and T-Mobile trade lower on the year. This analysis weighs dividends, cash fl...
Coca-Cola and PepsiCo enter 2026 with long dividend histories, but their cash flow realities diverge. This analysis w...
Markets wobble, but three names stand out for patient investors. Learn why Microsoft, NVIDIA, and The Trade Desk are ...
Lumen Technologies plans to shave $1B in annual network costs by 2027, driven by AI-enabled operations and a broader ...
On a volatile Friday, the Nasdaq is showing relative resilience while the Dow and S&P retreat. This article breaks do...
Ray Dalio’s Suez analogy returns to the headlines as markets weigh the U.S. risk of a reserve-currency shift and a we...
Nvidia stands at a crossroads as it prepares to report Feb earnings. This article unpacks why the result could redefi...
Geopolitics rattle markets, and a potential Iran conflict is no exception. This guide breaks down how stocks, oil, an...
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
Broadcom faced a rough June as the stock fell about 15%. This article breaks down what happened, why it matters, and ...